Author Archives: donttradeourlivesaway

Health groups irked by Supreme Court order on vaccine PSUs; mull fresh petition

on behalf of the All India Drug Action Network (AIDAN) and co-petitioners 19 February 2018 Several health groups expressed their strong disappointment with the order of the Supreme Court (SC) of February 12, 2018, which refused to review or recall … Continue reading

Posted in Generics, Uncategorized | Leave a comment

The scalpels are out ahead of ‘Special 301’ Report

 by PT Jyothi Datta | The HinduBusinessLine Indian pharma pushes back against US trade body’s criticism of its IPR protection record For the past five years, a lone Indian pharmaceutical representation goes out to the Office of the US Trade … Continue reading

Posted in IPR, Special 301 report, Uncategorized | Leave a comment

How Meaningful Is India’s Improved Ranking On Intellectual Property Index?

By Payaswini Upadhyay, Source: BloombergQuint | February 12, 2018 India’s ranking improved among 50 countries in the annual International IP Index this year on better protection for trademarks and copyrights and easier rules to patent computer-related innovations. The U.S. Chamber of Commerce … Continue reading

Posted in IPR, Uncategorized | Leave a comment

Malaysia drops four spots to 23rd place in global IP protection

Source: The Edge Markets KUALA LUMPUR: Malaysia dropped four spots to 23rd place in the sixth annual US Chamber International Intellectual Property Index following an episode of compulsory licensing related to a medicine in 2017, which was seen as a … Continue reading

Posted in IPR, Uncategorized | Leave a comment

India’s Global Intellectual Property Index Ranking Improves, Climbs to 44 out of 50

Source: IANS Published: IndiaWest NEW DELHI — India has substantially improved its ranking, to 44, in the latest Global Intellectual Property Index released by the U.S. Chambers of Commerce Feb. 8. According to the annual report by the Global Innovation Policy … Continue reading

Posted in IPR, Uncategorized | Leave a comment

MSF Challenges Pfizer’s Monopoly on Lifesaving Pneumonia Vaccine in Korea

Doctors Without Borders urges Pfizer to drop unmerited patents that hinder access to lifesaving childhood vaccine worldwide  NEW YORK/SEOUL, FEBRUARY 6, 2018—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is in the process of submitting a legal … Continue reading

Posted in Patent, Patent Opposition, Uncategorized, Vaccines | Leave a comment

PhRMA is angered by Colombia’s move to cut prices for hepatitis C drugs

By Ed Silverman, StatNews In the latest battle between drug makers and the Colombian government,  an industry trade group has asked the Colombian health minister to scrap a move that is designed to unilaterally lower the prices of hepatitis C drugs or, eventually, issue compulsory licenses. … Continue reading

Posted in Compulsory Licensing, Drug prices, Hepatitis C, Uncategorized | Leave a comment